Estrogen and progesterone receptors and pS2 and ERD5 antigens in gastric carcinomas from the European population

Modern Pathology

Volumn 9, Issue 3, 1996, Pages 189-193

  Chaubert, Pascal ^a   Bouzourene, Hanifa ^a   Saraga, Emilia ^a  

^a UNIVERSITY INSTITUTE OF PATHOLOGY   (Switzerland)

Author keywords

ERD5; Estrogen receptors; Immunohistochemistry; Progesterone receptors; pS2; Stomach

Indexed keywords

ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; STOMACH CARCINOMA;

CARCINOMA; EUROPE; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASM PROTEINS; PROTEINS; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEINS;

EID: 0029867664     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Harrison JD, Morris DL, Ellis O, Jones JA, Jackson I: The effect of Tamoxifen and estrogen receptor status on survival in gastric carcinoma. Cancer 64:1007, 1989.
2. Wu CW, Lui WY, P'eng FK, Chi CW: Hormonal therapy for stomach cancer. Med Hypotheses 39:137, 1992.
3. Harrison JD, Watson S, Morris DL: The effect of sex hormones and Tamoxifen on the growth of human gastric and colorectal cancer cell lines. Cancer 63:2148, 1989.
4. Wu CW, Tsay SH, Chang TJ, et al.: Clinicopathologic comparisons between estrogen receptor-positive and -negative gastric cancers. J Surg Oncol 51:231, 1992.
5. Matsui M, Kojima O, Uehara Y, Takahashi T: Characterization of estrogen receptor in human gastric cancer. Cancer 68:305, 1991.
6. Kojima O, Takahashi T, Kawakami S, Uehara Y, Matsui M: Localization of estrogen receptors in gastric cancer using immunohistochemical staining of monoclonal antibody. Cancer 67:2401, 1991.
7. Wu CW, Chang HM, Kao HL, et al.: The nontransformed progesterone and estrogen receptors in gastric cancer. Gastroenterology 102:1639, 1992.
8. Tokunaga A, Nishi K, Matsukura N, et al.: Estrogen and progesterone receptors in gastric cancer. Cancer 57:1376, 1986.
9. Yokozaki H, Takekura N, Takanashi A, et al.: Estrogen receptors in gastric adenocarcinoma: A retrospective immunohistochemical analysis. Virchows Arch A Pathol Anat Histol 413:297, 1988.
10. Matsui M, Kojima O, Kawakami S, Uehara Y, Takahashi T: The prognosis of patients with gastric cancer possessing sex hormone receptors. Jpn J Surg 22:421, 1992.
11. Wu CW, Chi CW, Chang TJ, Lui WY, P'eng FK: Sex hormone receptors in gastric cancer. Cancer 65:1396, 1990.
12. Linsalata M, Messa C, Russo F, Cavallini A, Di Leo A: Estrogen receptors and polyamine levels in human gastric carcinoma. Scand J Gastroenterol 29:67, 1994.
13. Johansson J, Thulin L, Fernö M, Andrén-Sandberg A: Estrogen receptors in gastric cancer. Acta Oncol 30:870, 1991.
14. Sica V, Nola E, Contieri E, et al.: Estradiol and progesterone receptors in malignant gastrointestinal tumors. Cancer Res 44:4670, 1984.
15. Cameron BL, Butler JA, Rutgers J, et al.: Immunohistochemical determination of the estrogen receptor content of gastrointestinal adenocarcinomas. Am Surg 58:758, 1992.
16. Seitz G, Welter C, Khorsandian D, et al.: Immunohistochemical demonstration of breast cancer-associated pS2 protein in gastrointestinal carcinomas (abstract). J Cancer Res Clin Oncol 115:48, 1989.
17. Deamant FD, Pombo MT, Battifora H: Estrogen receptor immunohistochemistry as a predictor of site of origin in metastatic breast cancer. Appl Immunohistochem 1:188, 1993.
18. Home GM, Angus B, Wright C, et al.: Relationships between oestrogen receptor, epidermal growth factor receptor ERD5, and p24 oestrogen-regulated protein in human breast cancer. J Pathol 155:143, 1988.
19. King RJB, Coffer AI, Gilbert J, et al.: Histochemical studies with a monoclonal antibody raised against a partially purified soluble estradiol receptor preparation from human myometrium. Cancer Res 45:5728, 1985.
20. Cano A, Coffer AI, Adatia R, et al.: Histochemical studies with an estrogen receptor related protein in human breast tumors. Cancer Res 46:6475, 1986.
21. Smyth CM, Benn DE, Reeve TS: Comparison of an estrogen related protein, the ERD5 antigen, with estrogen and progesterone receptors in breast cancer patients. Pathology 19:219, 1987.
22. Bilous AM, Tyler JPP, Toppila M, Milliken J: Whither cytosolic estrogen receptor assays? A comparison of commercially available kits for estrogen receptor assay. Pathology 19:223, 1987.
23. Masiakowski P, Breathnach R, Bloch J, et al.: Cloning of c-DNA sequences of hormone-regulated genes from the MCF-7 human breast cancer cell line. Nucleic Acids Res 10:7895, 1982.
24. Jakowlev SB, Breathnach R, Jeltsch JM, Masiakowski P, Chambon P: Sequence of the pS2 mRNA induced by estrogen in the human breast cancer line MCF-7. Nucleic Acids Res 12:2861, 1984.
25. Henry JA, Piggott NH, Mallick UK, et al.: pNR-2/pS2 immunohistochemical staining in breast cancer: Correlation with prognostic factors and endocrine response. Br J Cancer 63: 615, 1991.
26. Rio MC, Bellocq JP, Gairard B, et al.: Specific expression of the pS2 gene in subclasses of breast cancers in comparison with expression of the estrogen and progesterone receptors and the oncogene ERBB2. Proc Natl Acad Sci U S A 84:9243, 1987.
27. Hurlimann J, Gebhard S, Gomez F: Oestrogen receptor, progesterone receptor, pS2 ERD5 HSP27, and cathepsin D in invasive ductal breast carcinomas. Histopathology 23:239, 1993.
28. Foekens JA, Rio MC, Seguin P, et al.: Prediction of relapse and survival in breast cancer patients by pS2 protein status. Cancer Res 50:3832, 1990.
29. Nunez AM, Berry M, Imler JL, Chambon P: The 5′-flanking region of the pS2 gene contains a complex enhancer region responsive to oestrogens, epidermal growth factor, a tumour promoter (TPA), the c-Ha-ras oncoprotein and the c-jun protein. EMBO J 8:823, 1989.
30. Harrison JD, Jones JA, Ellis IO, Morris DL: Oestrogen receptor D5 antibody is an independent negative prognostic factor in gastric cancer. Br J Surg 78:334, 1991.
31. Henry JA, Bennett MK, Piggott NH, et al.: Expression of the pNR-2/pS2 protein in diverse human epithelial tumours. Br J Cancer 64:677, 1991.
32. Müller W, Borchard F: pS2 protein in gastric carcinoma and normal mucosa: Association with clinicopathological parameters and patient survival. J Pathol 171:263, 1993.
33. Lauren P: The two histological main types of gastric carcinoma: Diffuse and so-called intestinal-type carcinoma. Acta Pathol Microbiol Scand 64:31, 1965.
34. Hurlimann J, Saraga EP: Expression of p53 protein in gastric carcinomas. Association with histologic type and prognosis. Am J Surg Pathol 18:1247, 1994.
35. Sternberger LA, Hardy PH Jr, Cuculis J, Meyer HG: The unlabeled antibody enzyme method of immunohistochemistry. Preparation and properties of soluble antigen-antibody complex (horseradish peroxidase-antihorseradish peroxidase) and its use in identification of spirochetes. J Histochem Cytochem 18:315, 1970.
36. Shi SR, Key ME, Karla KL: Antigen retrieval in formalin-fixed, paraffin-embedded tissues: An enhancement method for immunohistochemical staining based on microwave oven heating on tissue sections. J Histochem Cytochem 39:741, 1991.
37. Saitoh Y, Sasano H, Naganuma H, et al.: De novo expression of aromatase in gastric carcinoma. Pathol Res Pract 188:53, 1992.
38. McCulloch PG, Ochiai A, O'Dowd GM, et al.: Comparison of the molecular genetics of c-erb-B2 and p53 expression in stomach cancer in Britain and Japan. Cancer 75:920, 1995.
39. Helin HJ, Helle MJ, Heiin ML, Isola JJ: Immunocytochemical detection of estrogen and progesterone receptors in 124 human breast cancers. Am J Clin Pathol 89:137, 1988.
40. Battifora H: Metastatic breast carcinoma to the stomach simulating linitis plastica. Appl Immunohistochem 2:225, 1994.
41. Chaubert P, Hurlimann J: Mammary origin of metastases. Immunohistochemical determination. Arch Pathol Lab Med 116:1181, 1992.
42. Rio MC, Bellocq JP, Daniel JY, et al.: Breast cancer-associated pS2 protein: Synthesis and secretion by normal stomach mucosa. Science 241:705, 1988.